TDOC

Teladoc Health, Inc. [TDOC] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

TDOC Stock Summary

Top 10 Correlated ETFs

TDOC


Top 10 Correlated Stocks

TDOC


In the News

07:39 26 Sep 2023 TDOC

Investor Alert: 3 Red-Hot Opportunities You Can't Afford to Miss

Among thousands of stocks, the article lists three companies that have defied expectations and emerged as industry titans. They are poised to shape the future of healthcare, entertainment, and consumer technology.

07:13 26 Sep 2023 TDOC

The 5 Best Healthcare Stocks to Buy Now: September 2023

In today's dynamic market, many investors are paying attention to the healthcare sector. The segment is known for its resilience and potential for growth.

09:45 26 Sep 2023 TDOC

3 Absurdly Discounted Stocks That Are Too Cheap to Ignore

Teladoc, Disney, and PayPal are all leaders in their industries. Yet, the shares of all three are trading near multi-year lows.

09:37 26 Sep 2023 TDOC

4 Encouraging Trends for Teladoc Health

Teladoc Health's business has been slowing down, but revenue still increased 10% last quarter. The number of virtual visits hasn't fallen off a cliff despite the economy's return to normal.

03:19 26 Sep 2023 TDOC

5 Meme Stocks to Sell Immediately, According to AI

Last week, I revealed MarketMaster AI , a set of deep learning AI algorithms designed to beat the market. The system was flashing warning signals like a hyperactive lifeguard on duty.

09:30 26 Sep 2023 TDOC

A Bull Market Is Coming: 2 Beaten-Down Stocks to Buy and Hold

Teladoc's solid position in telemedicine, improving bottom line, and strong margins make a solid case for the stock. Tandem Diabetes Care develops cutting-edge insulin pumps for diabetes patients, an area with plenty of white space.

05:54 26 Sep 2023 TDOC

Buy Teladoc: AI Will Likely Spur Healthcare Deflation

Aging demographics and rising healthcare costs are major concerns for the global economy. Artificial Intelligence has the potential to significantly reduce healthcare costs and improve diagnosis and treatment plans. Teledoc, in partnership with Microsoft, is well-positioned to utilize AI and become a leader in bringing down healthcare costs.

09:39 26 Sep 2023 TDOC

7 Dirt-Cheap Stocks to Buy in August

The allure of high-potential dirt-cheap stocks often tempts those looking for the next big win. This year has seen some market sectors skyrocket while others remain in the shadows, with untapped potential.

10:15 26 Sep 2023 TDOC

2 Stocks With Solid Earnings Report to Buy Right Now

After a challenging few years, Teladoc's bottom line and margins are moving in the right direction. Roku is seeing its revenue growth rebound and expenses drop thanks to a recovering economy.

09:14 26 Sep 2023 TDOC

Why Teladoc Health Could Be an Extremely Underrated Buy

Teladoc's stock gained momentum since it released an encouraging earnings report last week. The company is no longer incurring hefty impairment losses, as its bottom line has been improving.

TDOC Financial details

Company Rating
Neutral
Market Cap
3.1B
Income
-4.02B
Revenue
2.53B
Book val./share
13.98
Cash/share
5.84
Dividend
-
Dividend %
-
Employees
4.82K
Optionable
No
Shortable
Yes
Earnings
24 Oct 2023
P/E
-0.77
Forward P/E
-
PEG
-0.01
P/S
1.22
P/B
1.34
P/C
3.26
P/FCF
48.69
Quick Ratio
3.06
Current Ratio
3.45
Debt / Equity
0.69
LT Debt / Equity
0.69
-
-
EPS (TTM)
-24.76
EPS next Y
-
EPS next Q
-0.93
EPS this Y
2998.9%
EPS next Y
-
EPS next 5Y
47.09%
EPS last 5Y
124.91%
Revenue last 5Y
41.93%
Revenue Q/Q
3.68%
EPS Q/Q
-4.76%
-
-
-
-
SMA20
-13.04%
SMA50
-16.67%
SMA100
-23.08%
Inst Own
81%
Inst Trans
0.94%
ROA
-93%
ROE
-124%
ROC
0.91%
Gross Margin
70%
Oper. Margin
142%
Profit Margin
-159%
Payout
-
Shs Outstand
164.95M
Shs Float
163.7M
-
-
-
-
Target Price
58.61
52W Range
18.72-34.73
52W High
-43.97%
52W Low
+5.83%
RSI
22
Rel Volume
0.73
Avg Volume
5.43M
Volume
3.97M
Perf Week
-10.14%
Perf Month
-19.99%
Perf Quarter
-27.1%
Perf Half Y
-23.98%
-
-
-
-
Beta
1.10201
-
-
Volatility
0.86%, 1.36%
Prev Close
1.44%
Price
19.05
Change
-2.71%

TDOC Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
Revenue per share
6.357.712.0912.9514.91
Net income per share
-1.47-1.38-5.36-2.73-84.6
Operating cash flow per share
-0.070.42-0.591.241.17
Free cash flow per share
-0.20.26-0.880.830.1
Cash per share
7.277.28.695.715.69
Book value per share
15.3914.11175.49102.2414.29
Tangible book value per share
0.430.59-7.94-2.35-3.73
Share holders equity per share
15.3914.11175.49102.2414.29
Interest debt per share
6.736.9516.868.679.89
Market cap
3.26B6.01B18.1B14.41B3.82B
Enterprise value
3.25B5.97B18.83B14.78B4.47B
P/E ratio
-33.62-60.84-37.31-33.61-0.28
Price to sales ratio
7.8110.8716.547.091.59
POCF ratio
-671.59201.37-338.2274.2820.17
PFCF ratio
-246.02317.09-227.5110.8231.03
P/B Ratio
3.225.931.140.91.65
PTB ratio
3.225.931.140.91.65
EV to sales
7.7910.7817.217.271.86
Enterprise value over EBITDA
-107.2-206.65-55.37-1.04K0.33
EV to operating cash flow
-669.68199.73-351.8976.2123.63
EV to free cash flow
-245.32314.51-236.7113.68270.67
Earnings yield
-0.03-0.02-0.03-0.03-3.58
Free cash flow yield
0000.010
Debt to equity
0.410.460.090.080.69
Debt to assets
0.270.290.080.070.37
Net debt to EBITDA
0.311.7-2.15-26.190.05
Current ratio
8.536.523.193.73.29
Interest coverage
-2.71-2.54-6.91-2.971.42K
Income quality
0.05-0.30.11-0.45-0.01
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.280.30.460.220.19
Research and developement to revenue
0.130.120.150.150.14
Intangibles to total assets
0.640.610.940.930.67
Capex to operating cash flow
1.73-0.360.49-0.33-0.91
Capex to revenue
-0.02-0.02-0.02-0.03-0.07
Capex to depreciation
-0.24-0.24-0.33-0.29-0.64
Stock based compensation to revenue
0.10.120.430.150.09
Graham number
22.5920.9145.4879.28164.95
ROIC
-0.05-0.04-0.02-0.023.36
Return on tangible assets
-0.18-0.16-0.42-0.32-9.52
Graham Net
-0.07-0.4-10.27-4.01-5.78
Working capital
470.3M497.82M726.96M894.43M915.62M
Tangible asset value
28.53M42.49M-718.32M-368.7M-602.21M
Net current asset value
16.98M-800K-811.87M-463.41M-722.22M
Invested capital
0.410.460.090.080.69
Average receivables
35.33M50.26M113.11M169.12M189.76M
Average payables
5.83M8.42M27.55M46.64M47.47M
Average inventory
0028.25M64.79M64.71M
Days sales outstanding
38.0537.5756.4830.3431.93
Days payables outstanding
22.0317.9642.9926.5323.4
Days of inventory on hand
0052.7641.0227.64
Receivables turnover
9.599.726.4612.0311.43
Payables turnover
16.5720.338.4913.7615.6
Inventory turnover
006.928.913.2
ROE
-0.1-0.1-0.03-0.03-5.92
Capex per share
-0.13-0.15-0.29-0.41-1.07

Quarterly Fundamentals Overview

Last date of statement is 2023-06-30 for Q2

Metric History 2022-06-302022-09-302022-12-312023-03-31 2023-06-30
Revenue per share
3.673.783.933.863.97
Net income per share
-19.22-0.45-23.49-0.42-0.4
Operating cash flow per share
0.570.390.40.080.62
Free cash flow per share
0.30.120.07-0.20.39
Cash per share
5.485.565.665.455.84
Book value per share
37.737.4214.2314.0613.98
Tangible book value per share
-4-4-3.71-3.67-3.42
Share holders equity per share
37.737.4214.2314.0613.98
Interest debt per share
9.889.839.779.719.69
Market cap
5.36B4.1B3.84B4.22B4.16B
Enterprise value
6.06B4.78B4.49B4.9B4.77B
P/E ratio
-0.43-13.95-0.25-15.24-15.94
Price to sales ratio
9.056.716.016.716.37
POCF ratio
57.9665.0558.51320.7441.08
PFCF ratio
112.52206.89328.99-129.9664.34
P/B Ratio
0.880.681.661.841.81
PTB ratio
0.880.681.661.841.81
EV to sales
10.227.817.047.797.31
Enterprise value over EBITDA
-3.08K-761.191.17200.05153.21
EV to operating cash flow
65.4975.7868.51372.747.16
EV to free cash flow
127.14241385.18-151.0273.85
Earnings yield
-0.58-0.02-0.99-0.02-0.02
Free cash flow yield
0.0100-0.010.02
Debt to equity
0.260.260.690.690.69
Debt to assets
0.20.20.370.370.37
Net debt to EBITDA
-354.39-107.730.1727.8919.75
Current ratio
3.383.133.293.373.45
Interest coverage
-14.68-52.11-1.98K13.43-8.17
Income quality
-0.03-0.86-0.02-0.19-1.55
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.190.180.190.180.21
Research and developement to revenue
0.140.140.130.140.13
Intangibles to total assets
0.830.830.670.670.66
Capex to operating cash flow
-0.48-0.69-0.82-3.47-0.36
Capex to revenue
-0.08-0.07-0.08-0.07-0.06
Capex to depreciation
-0.71-0.66-0.68-0.62-0.46
Stock based compensation to revenue
0.090.090.080.070.09
Graham number
127.6919.5686.7311.611.17
ROIC
-0.01-0.010.95-0.01-0.01
Return on tangible assets
-2.26-0.05-2.65-0.05-0.04
Graham Net
-5.89-6-5.76-5.8-5.39
Working capital
885.79M876.19M915.62M905.36M937.57M
Tangible asset value
-645.72M-647.6M-602.21M-597.91M-562.15M
Net current asset value
-760.86M-763.72M-722.22M-731.21M-700.3M
Invested capital
0.260.260.690.690.69
Average receivables
198.48M203.57M206.13M213.27M215.58M
Average payables
70.89M82.58M59.24M43.16M27.35M
Average inventory
65.46M59.8M57.84M51.07M39.93M
Days sales outstanding
31.2129.6929.7230.8929.68
Days payables outstanding
46.5534.3222.7218.297.59
Days of inventory on hand
29.7228.7726.8521.6816.09
Receivables turnover
2.883.033.032.913.03
Payables turnover
1.932.623.964.9211.86
Inventory turnover
3.033.133.354.155.6
ROE
-0.51-0.01-1.65-0.03-0.03
Capex per share
-0.28-0.27-0.33-0.28-0.22

TDOC Frequently Asked Questions

What is Teladoc Health, Inc. stock symbol ?

Teladoc Health, Inc. is a US stock , located in Purchase of Ny and trading under the symbol TDOC

Is Teladoc Health, Inc. buy or a sell ?

43 stock analysts have 43 predictions with a medium analyst target price of $63.95. The lowest prediction is $25 and the highest is $150

What is TDOC stock prediction ?

What is Teladoc Health, Inc. stock quote today ?

Teladoc Health, Inc. stock price is $19.05 today.

Is Teladoc Health, Inc. stock public?

Yes, Teladoc Health, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap